相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
1
- 供应商:
上海再康
Maintain at 2-8°C for 6 - 12 months. Further dilutions should be made into buffer or medium to which protein (e.g., 1% BSA) or Tween 20 has been added.
详细信息:
Leukemia Inhibitory Factor, recombinant mouse 重组小鼠白血病抑制因子
现货供应
Description: Leukemia Inhibitory Factor, recombinant mouse
Trade Name: Chemicon (Millipore)
Product Overview: Leukemia Inhibitory Factor (LIF) is a lymphoid factor which promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo. Mouse LIF is a 20 kDa protein containing 181 amino acid residues.
Leukemia Inhibitory Factor, recombinant mouseKey Applications:
Stem Cell Culture
Cell Culture
Application Notes: RECOMMENDED QC PROTOCOL
M1 Bioassay
1. The M1 bioassay is performed using in vitro semi-solid agar cultures, which contain approximately 100 cells in 1 mL volumes of DME containing 20 % FCS in 0.3% agar.
2. Add 100 μL of sample or mLIF (10(E4) units/mL in 5% FCS in isotonic saline) in two-fold serial dilutions in duplicate to 35 mm petri dishes.
3. Add 100 μL of 5% FCS in isotonic saline to two control slides.
4. Incubate at 37°C in fully humidified atmosphere of 10% CO2 in air for 7 days.
5. Score the number of colonies that show differentiation (note: 50 units is defined as the amount of activity which results in 50% of the colonies being differentiated).
Visit for additional information
Manufactured by CHEMICON International, Inc. LIF is protected under US Patent nos. 5,187,077, 5,427,925, 5,443,825, 5,750,654 and 6,261,548, European Patent no. 0285 448 and related foreign patents and is not available for resale.
Leukemia Inhibitory Factor, recombinant mouseUsage Statement:
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Species: Mouse
Stem Cell Type:
Mouse Embryonic Stem Cells
Neural Stem Cells
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Stem Cell Workflow Stage:
Maintenance & Expansion
Differentiation
General Cell Culture
Source: mLIF is expressed in E. coli as a fusion protein with GST using the pGEX expression system, cleaved from GST moeity with thrombin and purified by HPLC chromatography.
Presentation: Liquid in PBS, pH 7.4 and 0.02% Tween 20. No preservativies added.
Storage Conditions: Maintain at 2-8°C for 6 - 12 months. Further dilutions should be made into buffer or medium to which protein (e.g., 1% BSA) or Tween 20 has been added.
Manufactured by CHEMICON International, Inc. LIF is protected under US Patent nos. 5,187,077, 5,427,925, 5,443,825, 5,750,654 and 6,261,548, European Patent no. 0285 448 and related foreign patents and is not available for resale.
Specific Activity:
The activity of mouse LIF is determined by the ability to induce differentiation of murine M1 myeloid leukemic cells. The minimum detectable concentration of mouse LIF in this assay is 0.5 ng/mL. The specific activity is >=1 x 10(E8) units/mg, where 50 units is defined as the amount of mouse LIF required to induce differentiation in 50% of the M1 colonies in 1 mL agar cultures.
Cell Culture Reagent Type: Cytokines & Growth Factors
Protein or Enzyme Type: Cytokines & Growth Factors
Alternate Names: LIF; Differentiation-stimulating Factor; D Factor
Concentration: 10 μg/mL
Purity: Greater than 95% by analytical HPLC and SDS-PAGE. Endotoxin level is less than 0.1 ng per mg of LIF. Tested negative in both aseptic and microplasmic tests.
Leukemia Inhibitory Factor, recombinant mouse
LTEP-a-2 肺腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
MM96L 黑色素瘤 品牌ATCC 规格25毫升/株. 货期1-2周
SH-77 小细胞肺癌 品牌ATCC 规格25毫升/株. 货期1-2周
J-111 单核细胞白血病 品牌ATCC 规格25毫升/株. 货期1-2周
NCI-H446 小细胞肺癌 品牌ATCC 规格25毫升/株. 货期1-2周
Dami 巨核细胞 品牌ATCC 规格25毫升/株. 货期1-2周
SPC-A-1 肺腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
CHMas 肥大细胞白血病 品牌ATCC 规格25毫升/株. 货期1-2周
SGC-7901 胃腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
HEL 红细胞白血病 (Erythroleukemia) 品牌ATCC 规格25毫升/株. 货期1-2周
BGC-823 低分化胃腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
HL-60 原髓细胞白血病 (Promyelocytic lenukemia) 品牌ATCC 规格25毫升/株. 货期1-2周
LoVo 结肠腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
Hut-78 皮肤T细胞淋巴瘤 品牌ATCC 规格25毫升/株. 货期1-2周
Ls-174-T 结肠腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
Hut-102 皮肤T细胞淋巴瘤 品牌ATCC 规格25毫升/株. 货期1-2周
HCT-8 回盲肠腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
Namalwa Burkitt`s淋巴瘤 品牌ATCC 规格25毫升/株. 货期1-2周
HCe-8693 盲肠未分化腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
Jurknt. zkone E6-1 白血病细胞 品牌ATCC 规格25毫升/株. 货期1-2周
HR-8348 直肠腺癌 品牌ATCC 规格25毫升/株. 货期1-2周
THP-1 单核细胞 品牌ATCC 规格25毫升/株. 货期1-2周
BEL-7402 肝癌 品牌ATCC 规格25毫升/株. 货期1-2周
U937 组织细胞淋巴瘤 品牌ATCC 规格25毫升/株. 货期1-2周
BEL-7404 肝癌 品牌ATCC 规格25毫升/株. 货期1-2周
Raji Burkitt's淋巴瘤 品牌ATCC 规格25毫升/株. 货期1-2周
BEL-7405 肝癌 品牌ATCC 规格25毫升/株. 货期1-2周
MEG-01 成巨核细胞白血病 品牌ATCC 规格25毫升/株. 货期1-2周
HepG2 肝细胞癌 品牌ATCC 规格25毫升/株. 货期1-2周
L129 NCTC克隆929 品牌ATCC 规格25毫升/株. 货期1-2周
L-M TK 鼠胸腺激酶缺陷细胞株 品牌ATCC 规格25毫升/株. 货期1-2周
STO 鼠胚成纤维细胞系 品牌ATCC 规格25毫升/株. 货期1-2周
YAC-1 鼠T淋巴瘤细胞系 品牌ATCC 规格25毫升/株. 货期1-2周
MA-782 鼠乳腺癌细胞系 品牌ATCC 规格25毫升/株. 货期1-2周
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Acute myeloid leukemia (AML) has an annual incidence of 2.4 cases per 100,000 persons and is the most common form of acute leukemia in adults (1 , 2 ). AML is a model for drug-resistant human cancers, and current therapies for AML possess
Isolation and Culture of Mouse Germ Cells
cells have subsequently been found to be physiologically relevant to germ cell growth and development in vivo. For example, leukemia inhibitory factor (LIF) was identified as a potent germ cell survival factor and mitogen in culture (1 ). Subsequently
In Vitro Functional Study of miR-126 in Leukemia
MicroRNAs (miRNAs, miRs) are postulated to be important regulators in various cancers, including leukemia. In a large-scale miRNA expression profiling analysis of 435 human miRNAs in 52 acute myeloid leukemia (AML) samples, we found that miR
技术资料暂无技术资料 索取技术资料






